Ocuphire Pharma, Inc. (OCUP) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 728M |
| Enterprise Value | 682.91M |
| P/E Ratio | -2.74 |
| PEG Ratio | 0.06 |
| Price/Sales Ratio | 43.99 |
| Price/Book Ratio | 11.09 |
| Enterprise/Revenue | 37.12 |
| Enterprise/EBITDA | -2.19 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
| Profit Margin | -17.27 |
| Operating Margin | -7.78 |
| Return On Assets | -1.43 |
| Return On Equity | 108.39 |
| Revenue | 0 |
| Revenue/Share | 0.08 |
| Gross Profit | 0 |
| EBITDA | -38.6M |
| Net Income | -49.59M |
| Diluted EPS | -0.8 |
| Total Cash | 88.97M |
| Total Cash/Share | 0.87 |
| Total Debt | 34.53M |
| Total Debt/Equity | 0.9 |
| Current Ratio | 9.65 |
| Book Value Per Share | 0.38 |
| 52-Week Change | -58.36 |
| 52-Week High | 3.4 |
| 52-Week Low | 1.07 |
| Moving Average 50 Days | 1.27 |
| Moving Average 200 Days | 1.74 |
| Average Volume | 139,151 |
| Shares Outstanding | 27.13M |
| % Held by Institutions | 39.37 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:4 |
| Last Split Date | November 06, 2020 |